Efavirenz: practicalities, considerations and new issues.

  • Graeme J. Moyle
  • Published 1999 in
    International journal of clinical practice…


Concerns about the long-term safety issues with protease inhibitors (PIs) and recent reports of non-PI-containing regimens demonstrating potent and durable suppression of viral replication have brought into question the role of PI therapy. However, a number of issues surrounding PI-sparing regimens, such as the durability of the antiretroviral effect, the… (More)


Cite this paper

@article{Moyle1999EfavirenzPC, title={Efavirenz: practicalities, considerations and new issues.}, author={Graeme J. Moyle}, journal={International journal of clinical practice. Supplement}, year={1999}, volume={103}, pages={30-4} }